Phenprocoumon | Ld-DOAC | |||
Event rate per 100 py | Before matching | After matching | Before matching | After matching |
n | 20,179 | 14,818 | 21,724 | 14,818 |
Thromboembolic events | 2.53 | 2.83 | 4.42 | 3.93 |
Deceased | 7.45 | 8.57 | 18.51 | 15.01 |
Bleeding | 4.05 | 4.53 | 4.61 | 4.22 |
Phenprocoumon | Ld-Apixaban | |||
Event rate per 100 py | Before matching | After matching | Before matching | After matching |
n | 20,179 | 8991 | 10,997 | 8991 |
Thromboembolic events | 2.53 | 3.19 | 5.18 | 4.87 |
Deceased | 7.45 | 11.37 | 22.55 | 19.32 |
Bleeding | 4.05 | 5.31 | 4.26 | 4.12 |
Phenprocoumon | Ld-Dabigatran | |||
Event rate per 100 py | Before matching | After matching | Before matching | After matching |
n | 20,179 | 1908 | 1914 | 1908 |
Thromboembolic events | 2.53 | 3.09 | 3.59 | 3.59 |
Deceased | 7.45 | 9.42 | 9.49 | 9.23 |
Bleeding | 4.05 | 3.66 | 3.52 | 3.52 |
Phenprocoumon | Ld-Edoxaban | |||
Event rate per 100 py | Before matching | After matching | Before matching | After matching |
n | 20,179 | 2235 | 2255 | 2235 |
Thromboembolic events | 2.53 | 3.23 | 3.74 | 3.78 |
Deceased | 7.45 | 11.34 | 16.07 | 15.76 |
Bleeding | 4.05 | 4.98 | 4.84 | 4.82 |
Phenprocoumon | Ld-Rivaroxaban | |||
Event rate per 100 py | Before matching | After matching | Before matching | After matching |
n | 20,179 | 6478 | 6558 | 6478 |
Thromboembolic events | 2.53 | 2.90 | 3.60 | 3.55 |
Deceased | 7.45 | 9.51 | 14.96 | 14.67 |
Bleeding | 4.05 | 4.83 | 5.48 | 5.35 |